ADMA - Company ID 0001368514
ADMA BIOLOGICS, INC. (ADMA) reported net income of $146.93M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $146.93M | -25.7% |
| FY 2024 | $197.70M | +801.1% |
| FY 2023 | -$28.20M | +57.2% |
| FY 2022 | -$65.90M | +8.0% |
| FY 2021 | -$71.65M | +5.4% |
| FY 2020 | -$75.75M | -56.9% |
| FY 2019 | -$48.28M | +26.6% |
| FY 2018 | -$65.74M | -50.2% |
| FY 2017 |
ADMA BIOLOGICS, INC. (ADMA) reported net income of $146.93M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ADMA BIOLOGICS, INC.'s net income grew from -$5.90M to $146.93M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$43.76M |
| -124.2% |
| FY 2016 | -$19.52M | -8.6% |
| FY 2015 | -$17.97M | -6.9% |
| FY 2014 | -$16.81M | -8.3% |
| FY 2013 | -$15.53M | -112.7% |
| FY 2012 | -$7.30M | -23.7% |
| FY 2011 | -$5.90M | - |